Drugs / MDMA
last change May 2026 re-read 3 minutes ago

MDMA

Developed for
bulimia nervosa
Investigated by
Icahn School of Medicine at Mount Sinai

Trials 1

20272028
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT07542145 May 2026 → Apr 2028 expected bulimia nervosa Icahn School of Medicine at Mount Sinai Recruiting No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as MDMA ClinicalTrials.gov intervention name — accepted as the source's own label NCT07542145 ↗